Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $39.04 +0.90%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.
For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Intrusion acquires VigilAigent, adding $3.5M in recurring revenue
- Beneficient CEO confirmed, former chief convicted in fiscal 2026 update
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
